Oakridge International Limited has reversed its fortunes with a 42% revenue increase to $3.45 million and a return to profitability in FY2026, driven by healthcare technology sales and strategic platform enhancements.
- 42% revenue increase to $3.45 million
- Profit of $109,171 after prior year loss
- Growth driven by nurse call and IoT healthcare tech
- No dividends declared amid reinvestment
- Stable director remuneration, no performance incentives
Revenue Surge and Profit Turnaround
Oakridge International Limited (ASX:OAK) has posted a marked turnaround for the year ended 30 June 2026, with revenue climbing 42% to $3.45 million and a return to profit of $109,171 from a prior year loss of $128,795. The growth stems from increased sales, underpinned by intensified business development efforts and a robust project pipeline across Australian healthcare sectors.
The company’s healthcare technology segment, particularly its nurse call systems and Internet of Things (IoT)-enabled assisted living solutions, drove the revenue gains. This follows a pattern of steady expansion and product innovation, including enhancements to its NuCaMS platform and integration with Microsoft Azure cloud services.
Product Development and Market Expansion
Oakridge continued to advance its healthcare technology offerings, aligning with the updated AS8311:2024 Nurse Call Standard. Key achievements included improved enterprise reporting capabilities, real-time location system (RTLS) call point development, and mobile application progress. The company also demonstrated early-stage enterprise reporting features and refined its LED and LCD annunciator displays.
On the market front, Oakridge expanded its partner network and delivered projects across multiple care settings, including hospitals, aged care, disability care, and supported independent living. Assisted living programs and integrated assistive technologies saw further deployment, supporting the company’s strategic focus on workflow efficiency and compliance solutions.
Financial Position and Operational Efficiency
The balance sheet shows net assets of $1.36 million, up from $902,246 the previous year, bolstered by increased contributed equity and improved cash flow from operations. The company reported a positive net cash inflow from operating activities of $127,028, reversing prior year outflows.
Expense management remained a priority, with continued refinement of operational processes and adoption of inventory platforms like Zoho Books enhancing internal controls. The company also progressed readiness for ISO 9001:2015 and ISO 27001 certifications, reinforcing its commitment to quality and security standards.
Governance and Remuneration Stability
Director and key management personnel remuneration remained stable at $247,992, with no short- or long-term performance incentives granted during the year. Executive chairman and CEO Con Unerkov, who holds a significant equity stake through Montague Capital Pty Ltd, continued in his dual role, supported by non-executive directors Peter Whelan and Wally Pastuch.
The auditor issued an unqualified opinion, highlighting the key audit matter of inventory valuation due to obsolescence provisions but confirming that disclosures and valuation were appropriate.
Legal and Contingent Liabilities
Oakridge disclosed ongoing legal uncertainty related to a Share Placement Agreement with Teko International Limited, with potential liabilities under review. The company also carries contingent liabilities tied to a royalty-based loan from a past grant, where future repayments are unlikely given the cessation of royalty income from the related software licence.
These contingencies warrant attention but have not materially affected the company’s reported financial position or profit for FY2026.
Bottom Line?
Oakridge International’s return to profit and revenue growth signals operational progress, but investors should watch how the company manages legal contingencies and converts its growing project pipeline into sustained earnings.
Questions in the middle?
- How will Oakridge convert its active project pipeline into recurring revenue streams in FY2027?
- What impact could the unresolved legal matters with Teko International have on future financials?
- Will Oakridge’s exploration of AI-enabled healthcare technologies translate into competitive advantage or new revenue?